| Qtr | Est | Actual | +/− |
|---|---|---|---|
| Q2'26 | $5.60 | - | - |
| Q1'26 | $4.77 | $5.15 | +8.0% |
| Q4'25 | $4.83 | $5.29 | +9.6% |
| Q3'25 | $5.01 | $5.64 | +12.5% |
| Q2'25 | $5.28 | $6.02 | +14.1% |
| Q1'25 | $4.26 | $4.90 | +15.0% |
| Qtr | Est | Actual | +/− |
|---|---|---|---|
| Q2'26 | $9.6B | - | - |
| Q1'26 | $8.6B | $8.6B | +0.5% |
| Q4'25 | $9.7B | $9.9B | +2.1% |
| Q3'25 | - | $9.6B | - |
| Q2'25 | - | $9.2B | - |
| Q1'25 | - | $8.1B | - |
Market Data
AMGN is currently trading at $361.61, giving Amgen Inc. a market cap of 196.12B and a P/E ratio of 25.1. Today's range spans $361.14–$368.06, with shares opening at $363.08 and moving down $1.78 (0.5%) from the prior close. DailyIQ's technical score sits at 82/100 (BUY) with a news sentiment reading of 70/100.
Over the past year AMGN has traded between $269.77 and $391.29 - the current price is +34.0% off the 52-week low and -7.6% from the high. 43 analysts cover the stock with a Hold consensus and a mean 12-month target of $355.66 (range $215.00–$427.00), implying downside of -1.6%.
AMGN is showing the kind of bullish setup that active managers add to on dips - 82/100 (BUY), bullish sentiment at 70/100, 196.12B market cap in Healthcare, price $361.61 (in the upper portion of its 52-week range). The current P/E ratio stands at 25.1. At this cap tier, the combination of technical confirmation and positive sentiment is what separates speculative bullish positions from high-conviction ones. Annual range: $269.77–$391.29. The setup is in the latter category.
What makes AMGN's BUY setup (82/100) particularly actionable at 196.12B in Healthcare capitalization is the scale-to-move ratio: large enough to feature on institutional mandates but not so large that the percentage upside is already compressed by index inertia. At $361.61 (in the upper portion of its 52-week range in $269.77–$391.29), with sentiment running bullish at 70/100, the setup rewards conviction-sized positioning more than it does speculative small bets.
Sentiment gathered from recent headlines
Most recent articles, ranked by recency (click to expand).